What Is XDx?
XDx is a molecular diagnostics company focused on the discovery, development and commercialization of non-invasive gene expression testing in the areas of transplant medicine and autoimmunity. The company has developed a proprietary method of utilizing gene expression in blood that provides a new tool for physicians to manage the care of heart transplant patients.
The molecular expression technology developed and implemented by XDx in heart transplant patient management is currently being explored to assist with other diseases that involve the immune system.
Press Releases
XDx to Present at the Future Leaders in the Biotech Industry Conference
March 26, 2009
XDx Selected to Present at InsideVenture’s Debut Investor Conference
March 23, 2009
XDx and Bristol-Myers Squibb Enter into Pharmacogenomics Collaboration
January 9, 2009
XDx to Present at the 2008 In Vitro Diagnostic
Regulatory and Reimbursement Conference November, 2008
FDA Clears Test to Help Doctors Manage Heart Transplant Patients August, 2008
XDx’s AlloMap® Gene Expression Test Cleared by U.S. Food and Drug Administration August, 2008








